Poll: When will Rapamycin go Mainstream?

#42

What if something better comes along before rapamycin has a chance to go truly mainstream? Interest and progress in longevity is accelerating. It might be that we never see rapamycin go mainstream, but perhaps another mTOR1 inhibitor (this is a good thing despite our attachment to rapamycin).

I’m eagerly awaiting the first part of the data from the 601 mTOR inhibitor screening :eyes:

1 Like
#43

Better would also have to be cheaper to displace Rapamycin as the leader.

1 Like
#44

That will come in time and with scaling. We shouldn’t sacrifice progress for pragmatism.

Anyway that was just my own bold prediction.

1 Like